An immune-related lncRNA signature for predicting overall survival and chemotherapy sensitivity in bladder cancer patients

Asian J Surg. 2024 Nov 29:S1015-9584(24)02515-6. doi: 10.1016/j.asjsur.2024.10.192. Online ahead of print.
No abstract available

Keywords: Bladder cancer; Checkpoint blockade therapy; Chemotherapeutics; Long noncoding RNA; Signature; Tumor-infiltrating immune cell.

Publication types

  • Letter